FDA Grants EUA for CDC 'Trioplex' MDx Including Zika Target | GenomeWeb

NEW YORK (GenomeWeb) – The US Food and Drug Administration today announced it has granted Emergency Use Authorization to a PCR-based assay developed by the US Centers for Disease Control and Prevention to detect Zika virus.

The Trioplex Real-time RT-PCR Assay tests patient samples for chikungunya, dengue, and Zika viruses in a single test. Symptoms of Zika, chikungunya, and dengue infection are similar and a PCR-based assay may be advantageous for early detection and because immunoassays reportedly tend to show cross-reactivity between these pathogens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.